Servizio Comunitario di Informazione in materia di Ricerca e Sviluppo - CORDIS

A new vaccine strategy against serogroup b meningococcal infection: from antigen discovery to clinical trials

Dal 2000-02-01 al 2003-04-01

Dettagli del progetto

Costo totale:

EUR 3 687 024

Contributo UE:

EUR 2 640 000

Coordinato in:

Belgium

Meccanismo di finanziamento:

CSC - Cost-sharing contracts

Obiettivo

Coordinatore

GLAXOSMITHKLINE BIOLOGICALS SA
Belgium
Rue de l'Institut 89
--- RIXENSART
Belgium
Contatto amministrativo: Jean-Paul PRIEELS

Partecipanti

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
France
Rue de Tolbiac, 101
75654 PARIS
France
See on map
Contatto amministrativo: Claude GRISCELLI
Fax: +30-2610997848
KAROLINSKA INSTITUTE
Sweden
Solnavagen 1
171 77 STOCKHOLM
Sweden
See on map
Contatto amministrativo: Heather MARSHALL-HEYMAN
E-mail
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN E.V.
Germany
Hofgartenstrasse 8
MUENCHEN
Germany
See on map
Contatto amministrativo: Hans LEHRACH
E-mail
MICROBIOLOGICAL RESEARCH AUTHORITY
United Kingdom
Porton Down
SP4 0JG SALISBURY
United Kingdom
Contatto amministrativo: Michael HARKER
NATIONAL BIOLOGICAL STANDARDS BOARD
United Kingdom
Blanche lane, South Mimms
POTTERS BAR
United Kingdom
Contatto amministrativo: Richard STEWART
NORWEGIAN INSTITUTE OF PUBLIC HEALTH
Norway
75,Geitmyrsveien 75 Torshov
0403 OSLO
Norway
See on map
Contatto amministrativo: Bodolf HAREIDE
THE NATIONAL HOSPITAL UNIVERSITY OF OSLO
Norway
Pilestredet 32
0027 OSLO
Norway
See on map
Contatto amministrativo: Inger STRAY LIEN
WISE & MUNRO LEARNING RESEARCH
Netherlands
8,Azaleastraat 85
2565 CD DEN HAAG
Netherlands
See on map
Contatto amministrativo: Hans AMESZ